1-10 of 10
bcl2 gene
Close
Sort by
Journal Articles

Navigating the nexus of MRD and novel agents in ALL

Anjali S. Advani, Edward A. Copelan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 9–16.
https://doi.org/10.1182/hematology.2019000008
Published: 2019
Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.
https://doi.org/10.1182/asheducation-2018.1.69
Published: 2018
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Impact of MYC on malignant behavior

German Ott
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 100–106.
https://doi.org/10.1182/asheducation-2014.1.100
Published: 2014
Journal Articles

Double-hit lymphomas: current paradigms and novel treatment approaches

Kieron Dunleavy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 107–112.
https://doi.org/10.1182/asheducation-2014.1.107
Published: 2014
Journal Articles

Understanding MYC -driven aggressive B-cell lymphomas: pathogenesis and classification

German Ott, Andreas Rosenwald, Elias Campo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 575–583.
https://doi.org/10.1182/asheducation-2013.1.575
Published: 2013
Journal Articles

Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer

Gordon C. Shore, Jean Viallet
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 226–230.
https://doi.org/10.1182/asheducation-2005.1.226
Published: 2005
Journal Articles

Biology and Management of Histologic Transformation of Indolent Lymphoma

Arnold S. Freedman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 314–320.
https://doi.org/10.1182/asheducation-2005.1.314
Published: 2005
Journal Articles

Rational Approaches to Design of Therapeutics Targeting Molecular Markers

Richard J. Klasa, Alan F. List, Bruce D. Cheson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2001) 2001 (1): 443–462.
https://doi.org/10.1182/asheducation-2001.1.443
Published: 2001